Virus Bunuh Kanser

Rawatan kanser ditemui :

Virus Penyakit Newcastle (NDV)

Selepas mereka membunuh para Nabi, ini adalah antara kesalahan Yahudi yang paling besar!!! CMP 4:59 5:10 !!! Pemilik pemilik syarikat ubat gergasi adalah milik Yahudi. Mereka tidak mahu menerima ubat kanser yang tidak boleh dipatenkan! Virus Penyakit Newcastle terbukti boleh membunuh sel kanser namun syarikat ubat gergasi tidak berminat membuat kajian kerana Virus ini tidak boleh dipatenkan! Cerita lanjut sila baca buku Fighting Cancer - A Non Toxic Approach to Treatment oleh Robert Gorter dan Erik Peper ms 132.

Ubat Kimoterapi bersifat toksik dan meracun sel yang normal juga. Radioterapi juga begitu, akan membunuh sel kanser dan juga sel normal! Tuan2 dan puan2 fikirkanlah masak masak betapa mereka tak kisah orang menderita dengan hebat akibat pembedahan radikal yang mengurangkan kualiti hidup, Kimoterapi yang meracun manusia dan juga Radioterapi yang mencacatkan sel sel normal. Mereka tidak pernah beritahu kita bahawasanya jika anda telah melalui Kimoterapi dan Radioterapi, ini akan membuatkan sistem imun anda lemah dan anda boleh mendapat kanser jenis lain pula akibat sistem pertahanan badan tidak lagi mampu memakan sel sel kanser yang baru ujud !!!

4:59 Hai orang orang yang beriman, ikutlah Allah dan ikutlah rasul dan orang orang yang mengurus pekerjaan dari kamu. Kalau kamu berbantah-bantah tentang sesuatu (perkara), hendaklah kamu kembalikan kepada Allah dan rasul, jika kamu beriman kepada Allah dan hari yang kemudian. Demikian itu lebih baik dan sebaik-baik jalan.

5:10 Orang2 yang kafir dan mendustakan ayat2 Kami, mereka itulah penghuni neraka.

5:11 Hai orang2 yang beriman, ingatlah akan nikmat Allah kepadamu, ketika satu kaum bercita cita hendak menyerangmu (membunuhmu) dengan tangannya, lalu Allah menahan mereka dari padamu dan takutlah kepada Allah. Dan kepada Allah hendaklah bertawakkal orang2 beriman.

5:12  Sesungguhnya Allah telah menerima janji setia dari Bani Israel dan Kami angkat diantara mereka 12 orang pengawas. Allah berfirman: Sesungguhnya Aku beserta kamu. Demi jika kamu dirikan sembahyang dan kamu bayarkan zakat dan kamu beriman kepada rasul2Ku, serta kamu tolong mereka itu dan kamu piutangi Allah dengan piutang yang baik, niscaya Aku ampuni kesalahanmu dan Aku masukkan kamu ke dalam syurga yang mengalir air sungai dibawahnya. Barang siapa yang kafir diantaramu sesudah itu, maka sesungguhnya telah sesat ia dari jalan yang lurus.

5:13 Oleh kerana pelanggaran mereka terhadap perjanjiannya, Kami kutuki mereka itu dan Kami jadikan hati mereka keras, (sehingga) mereka mengubah kalimat (Allah) daripada tempatnya, serta melupakan sebahagian dari apa yang telah diperingatkan kepada mereka. Engkau (ya Muhammad) senantiasa melihat orang2 yang khianat di antara mereka itu, kecuali sedikit di antara mereka; maka maafkanlah mereka itu dan bebaskanlah. Sesungguhnya Allah mengasihi orang2 berbuat kebaikan.

5:14 Dari orang2 yang berkata: Sesungguhnya kami orang2 Nasrani, telah Kami ambil perjanjian mereka, kemudian mereka melupakan sebahagian dari apa2 yang telah diperingatkan kepada mereka. Kemudian Kami timbulkan permusuhan dan kebencian sesama mereka, sampai hari kiamat. Nanti Allah akan mengabarkan kepada mereka apa2 yang telah mereka usahakan.

5:15 Hai ahli kitab, sesungguhnya telah datang kepadamu seorang Rasul Kami yang menerangkan kepadamu kebanyakkan yang kamu sembunyikan daripada Kitab (Taurat dan Injil), serta memaafkan daripada yang lain. Sesungguhnya telah datang kepadamu dari Allah nur (cahaya) dan Kitab yang menerangkan.

 

Newcastle disease virus: a promising vector for viral therapy, immune therapy, and gene therapy of cancer. http://www.ncbi.nlm.nih.gov/pubmed/19565923
 

Schirrmacher V, Fournier P.

Source

Division of Cellular Immunology (D010), German Cancer Research Center (DKFZ), Heidelberg, Germany.

Abstract

This review deals with the avian paramyxovirus Newcastle disease virus (NDV) and describes properties that explain its oncolytic activity, its tumor-selective replication behavior, and its immune-stimulatory capacity with human cells. The strong interferon response of normal cells upon contact with NDV appears to be the basis for the good tolerability of the virus in cancer patients and for its immune stimulatory properties, whereas the weak interferon response of tumor cells explains the tumor selectivity of replication and oncolysis. Various concepts for the use of this virus for cancer treatment are pointed out and results from clinical studies are summarized. Reverse genetics technology has made it possible recently to clone the genome and to introduce new foreign genes thus generating new recombinant viruses. These can, in the future, be used to transfer new therapeutic genes into tumors and also to immunize against new emerging pathogens. The modular nature of gene transcription, the undetectable rate of recombination, and the lack of a DNA phase in the replication cycle make NDV a suitable candidate for the rational design of a safe and stable vaccine and gene therapy vector.

 

 

Daripada : http://www.cancer.gov/cancertopics/pdq/cam/NDV/patient/page1
 

• Newcastle disease virus (NDV) is a virus that is of interest because it replicates (makes copies of itself) more quickly in human cancer cells than in most normal human cells and because it can kill these host cells (see Question 1).
• NDV can be used to directly kill cancer cells, or it can be given as a cancer vaccine. Cancer vaccines cause the body’s natural immune system to seek out and destroy cancer cells (see Question 4).
• The results of clinical trials (research studies) of NDV as a cancer treatment have not proved that it works (see Question 6).
• The US Food and Drug Administration has not approved NDV as a treatment for cancer (see Question 8). - Ketahuilah bahawasanya FDA di bawah telunjuk syarikat ubat gergasi Yahudi!!!

Newcastle disease virus (NDV): brief history of its oncolytic strains. http://www.ncbi.nlm.nih.gov/pubmed/10680736
 

Sinkovics JG, Horvath JC.

Source

Cancer Institute, St. Joseph's Hospital, and The University of South Florida College of Medicine, Tampa 33607, USA. jsinkovi@com1.med.usf.edu

Abstract

BACKGROUND:

While genetically engineered viruses are now being tested for the virus therapy of human cancers, some naturally occurring viruses display unmatched oncolytic activity. Newcastle disease virus (NDV) excels as an oncolytic agent.

OBJECTIVES:

As its virulence versus attenuation can be explained on molecular biological bases, it may be possible to develop or select highly oncolytic strains of NDV without adverse toxicity.

STUDY DESIGN:

Questions are posed as to the mechanisms of viral oncolysis, the appropriateness of tests to predict oncolytic activity of a given NDV strain and the best modes of administration for oncolytic effects. Answers are provided based on specific data or on considerations drawn from experience (the authors use NDV oncolysates to immunize against melanoma and kidney carcinoma) or from analogous clinical situations (therapeutic use of mumps or measles viruses).

RESULTS AND CONCLUSIONS:

NDV oncolysates probably suit better for immunotherapy (providing also active tumor-specific immunization) than massive repeated inoculations of NDV strains, especially when the NDV strain used is not proven to be oncolytic by appropriate pre-clinical tests.

 

http://www.avianbiotech.com/diseases/newcastle.htm
 

Description:	Newcastle disease virus (NDV) - A type strain for avian paramyxoviruses. Members of this family have a single stranded, linear, RNA, with an elliptical symmetry. The total genome is roughly 16,000 nucleotides. Replication of the the virus takes place in the cytoplasm of the host cell. NDV is a contagious and fatal viral disease affecting most species of birds. Clinical signs are extremely variable depending on the strain of virus, species and age of bird, concurrent disease, and preexisting immunity. Four broad clinical syndromes are recognized by scientists. They are Viscerotropic velogenic, Neurotropic velogenic, Mesogenic, and Lentogenic. NDV is so virulent that many birds die without showing any clinical signs. A death rate of almost 100 percent can occur in unvaccinated poultry flocks. NDV can infect and cause death even in vaccinated poultry. Fortunately NDV has not infected domestic chicken flocks in the United States since the last outbreak was eradicated in 1974.
Transmission:	NDV is spread primarily through direct contact between healthy birds and the bodily discharges of infected birds. The disease is transmitted through infected birds' droppings and secretions from the nose, mouth, and eyes. NDV spreads rapidly among birds kept in confinement, such as commercially raised chickens. High concentrations of the NDV are found in birds' bodily discharges; therefore, the disease can be spread easily by mechanical means. Virus-bearing material can be picked up on shoes and clothing and carried from an infected flock to a healthy one. NDV can survive for several weeks in a warm and humid environment on birds' feathers, manure, and other materials. It can survive indefinitely in frozen material. However, the virus is destroyed rapidly by dehydration and by the ultraviolet rays in sunlight. Smuggled pet birds, especially Amazon parrots from Latin America, pose a great risk of introducing NDV into the US. Amazon parrots that are carriers of the disease but do not show symptoms are capable of shedding NDV for more than 400 days.
Symptoms:	NDV affects the respiratory, nervous, and digestive systems. Symptoms are very variable depending on the strain of virus, species of bird, concurrent disease and preexisting immunity. The incubation period for the disease ranges from 2 to 15 days. An infected bird may exhibit the following signs: Respiratory: sneezing, gasping for air, nasal discharge, coughing birds. Digestive: greenish, watery diarrhea Nervousness, depression, muscular tremors, drooping wings, twisting of head and neck, circling, complete paralysis of birds. Partial to complete drop in egg production and thin-shelled eggs. Swelling of the tissues around the eyes and in the neck of birds. Sudden death of birds.
Prevention:	Although often not recognized as such Exotic Newcastle is a threat to the caged-bird industry. Birds illegally smuggled into the United States are not quarantined and tested by the US Department of Agriculture (USDA) and therefore may carry the exotic Newcastle virus. Owners of pet birds should: Request certification from suppliers that birds are legally imported or are of US stock, are healthy prior to shipment, and will be transported in new or thoroughly disinfected containers. Maintain records of all sales and shipments of flocks. Isolate all newly purchased birds for at least 30 days. Restrict movement of personnel between new and old birds. Amazon parrots are difficult to raise domestically. Anyone who is offering to sell a large number of young parrots could be suspected of smuggling or purchasing smuggled birds.
Treatment:	There is no known treatment for Newcastle Disease.
Diagnosis:	Enzyme Linked Immunosorbant Assay (ELISA), PCR, Sequence technology.
Sample:	For routine isolation of NDV from chickens, turkeys, and other birds, samples are obtained by swabbing the trachea and the cloaca. Cotton swabs can be used. The virus can also be isolated from the lungs, brain spleen, liver, and kidneys.
Handling:	Prior to shipping samples should be stored at 4 C. (refrigerator). Samples must be shipped in a padded envelope or box. Samples may be sent by regular mail, but overnight is recommended.

 

Common virus 'kills cancer'

Wednesday, June 22, 2005; Posted: 9:17 a.m. EDT (13:17 GMT) Wednesday, June 22, 2005

The virus targets cancer cells, but does not harm normal cells, researchers said. Cancer Diseases WASHINGTON -- A common virus that is harmless to people can destroy cancerous cells in the body and might be developed into a new cancer therapy, US researchers said. The virus, called adeno-associated virus type 2, or AAV-2, infects an estimated 80 percent of the population. "Our results suggest that adeno-associated virus type 2, which infects the majority of the population but has no known ill effects, kills multiple types of cancer cells yet has no effect on healthy cells," said Craig Meyers, a professor of microbiology and immunology at the Penn State College of Medicine in Pennsylvania. "We believe that AAV-2 recognizes that the cancer cells are abnormal and destroys them. This suggests that AAV-2 has great potential to be developed as an anti-cancer agent," Meyers said in a statement.

He said at a meeting of the American Society for Virology that studies have shown women infected with AAV-2 who are also infected with a cancer-causing wart virus called HPV develop cervical cancer less frequently than uninfected women do.

AAV-2 is a small virus that cannot replicate itself without the help of another virus.

But with the help of a second virus it kills cells. For their study, Meyers and colleagues first infected a batch of human cells with HPV, some strains of which cause cervical cancer. They then infected these cells and normal cells with AAV-2.

After six days, all the HPV-infected cells died.

The same thing happened with cervical, breast, prostate and squamous cell tumor cells. All are cancers of the epithelial cells, which include skin cells and other cells that line the insides and outsides of organs. "One of the most compelling findings is that AAV-2 appears to have no pathologic effects on healthy cells," Meyers said. "So many cancer therapies are as poisonous to healthy cells as they are to cancer cells. A therapy that is able to distinguish between healthy and cancer cells could be less difficult to endure for those with cancer." AAV-2 is being studied intensively as a gene therapy vector -- a virus modified to carry disease-correcting genes into the body. Gene therapy researchers favor it because it does not seem to cause disease or immune system reaction on its own.